Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial.
Stringer D, Gardner L, Shaw O, Clarke B, Briggs D, Worthington J, Buckland M, Danzi G, Hilton R, Picton M, Thuraisingham R, Borrows R, Baker R, McCullough K, Stoves J, Phanish M, Shah S, Shiu KY, Walsh SB, Ahmed A, Ayub W, Hegarty J, Tinch-Taylor R, Georgiou E, Bidad N, Kılıç A, Moon Z, Horne R, McCrone P, Kelly J, Murphy C, Peacock J, Dorling A.
Stringer D, et al.
EClinicalMedicine. 2023 Jan 12;56:101819. doi: 10.1016/j.eclinm.2022.101819. eCollection 2023 Feb.
EClinicalMedicine. 2023.
PMID: 36684392
Free PMC article.
INTERPRETATION: Intervention to improve adherence and optimize immunosuppression does not delay failure of renal transplants after development of DSA. Whilst DSA predicts increased risk of allograft failure, novel interventions are needed before screening can be used to di …
INTERPRETATION: Intervention to improve adherence and optimize immunosuppression does not delay failure of renal transplants after de …